Elevated expression of RNF7, TCEB1, SOCS1, and SOCS3 genes encoding CRL5 components can predict poor prognosis of GBM, and strategies targeting CRL5 may inhibit the progression of GBM (Figure 3). The gene discussed is SOCS1; the disease is glioblastoma.